Clinical Trial Update: Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial results for serum bovine immunoglobulin protein isolate assessing quality of life and postoperative recovery in women with gynecologic cancer afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Reproductive Cancer
• Gynecologic Cancer

Drugs mentioned

• Serum Bovine Immunoglobulin Protein Isolate (bovine immunoglobulin protein isolate)

Snippet

Sponsor: Mayo Clinic | Conditions: Female Reproductive Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-04-01